The Deal
Monday, November 23, 
3:37 pm

Entries tagged "Sirtris Pharmaceuticals"

Just In: Advisers on GlaxoSmithKline's acquisition of Sirtris

Drug giant GlaxoSmithKline plc will buy clinical-stage biotech Sirtris Pharmaceuticals Inc. for $720 million. GlaxoSmithKline plc's legal counsel include Victor Lewkow, Arthur Kohn and Lillian Raben of Cleary Gottlieb Steen & Hamilton LLP. Sirtris turned to investment bankers Douglas Braunstein and Robbie Huffines of J.P. Morgan & Chase Co. For legal advice Sitris used Marc Rubenstein and Jonathan Grandon of Ropes & Gray LLP. ...



Top tags

You have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "Sirtris Pharmaceuticals." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.

More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Loan-to-buy

By Steven Miller, Standard & Poor's

Paulson's proposal to purchase an equity stake in Yellow Pages publisher Idearc is the second time in recent months an investor group has used its prepetition debt position to execute a bargain price 'exit LBO.'


Industry Insight

Managing your shareholder base

By Bradford P. Weirick and Joelle Khoury, Gibson Dunn

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

By Derek Watson, KPMG

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.